908 Devices Inc. (MASS): Capital Expenditures
$955.0K
Year ended 2025-12-31
$876.0K
Trailing 12 months to 2026-06-30
-22.4%
3-year compound annual growth
n/m
5-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $955.0K | +58.6% | 2026-03-09, From 2025-01-01 |
| 2024-12-31 | $602.0K | -70.6% | 2026-03-09, From 2024-01-01 |
| 2023-12-31 | $2.04M | 0.0% | 2025-03-07, From 2023-01-01 |
| 2022-12-31 | $2.04M | +177.5% | 2024-03-08, From 2022-01-01 |
| 2021-12-31 | $737.0K | n/m | 2023-03-15, From 2021-01-01 |
| 2020-12-31 | $9.0K | n/a | 2022-03-11, From 2020-01-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| 908 Devices Inc. (MASS) | 2025-12-31 | $955.0K | +58.6% |
| Harvard Bioscience Inc (HBIO) | 2025-12-31 | $1.26M | -52.4% |
| Rapid Micro Biosystems, Inc. (RPID) | 2025-12-31 | $850.0K | -37.7% |
| EyePoint, Inc. (EYPT) | 2025-12-31 | $3.28M | -19.1% |
| Precipio, Inc. (PRPO) | 2025-12-31 | $326.0K | +46.2% |
| Quanterix Corp (QTRX) | 2025-12-31 | $2.61M | -22.4% |
| Pacific Biosciences of California, Inc. (PACB) | 2025-12-31 | $2.71M | -56.1% |
| Seer, Inc. (SEER) | 2025-12-31 | $1.80M | -49.9% |
| Cytek Biosciences, Inc. (CTKB) | 2025-12-31 | $4.08M | +15.9% |
Compare MASS, HBIO, RPID, EYPT side by side · Screen every company in Laboratory Analytical Instruments ↗